SEOUL, South Korea,
April 3, 2019 /PRNewswire/
-- West Pharmaceutical Services, Inc. (NYSE: WST), a global
leader in innovative solutions for injectable drug administration,
today announced it has expanded its presence in the Asia Pacific region with a new sales office in
Korea—West Pharmaceutical Services Korea Ltd. This new office is
the result of West's purchase of the distribution business of GIS
Korea Ltd., a privately-owned medical device and healthcare
products distributor serving the Korean market, who previously
served as West's distributor in the region.
"We are excited to build upon the strong foundation that our
distributor has established in Korea, as this is an important
market for West and our customers," said Karen Flynn, Senior Vice President and Chief
Commercial Officer, West. "By combining the local insight of the
GIS Korea Team with West's global manufacturing reach and
market-leading technical support team, we will be able to better
serve our customers and position ourselves to grow our business in
this region."
"Korean pharmaceutical and biotech companies are making great
strides to bring new medicines to market, and our team has been
working by their side with West's products and services to help
them package and deliver their products, so they are delivered
safely and effectively to patients," said Kwon Dong-Oh, Managing Director for West, Korea
and former Managing Director for GIS Korea. "We are excited to join
West and to be a part of a global team that is working to improve
patient lives."
GIS has been partnering with West as a distributor since 2003
and has built an extensive network of customers across all
segments. West has been operating for more than 95 years,
delivering integrated containment and delivery solutions to
customers, tailored to the specific needs of its pharmaceutical,
biologic, generics, and medical device customer groups across the
globe. With offices in Singapore,
China, India, and Australia, and alongside our partner Daikyo
Seiko, Ltd.'s presence in Japan,
West is well-positioned to continue to address the increasing
customer demand in this region.
Forward-Looking Statements
Certain forward-looking statements are included in this
release. They use such words as "will," "position," "grow,"
"are making," "well-positioned," "continue," "increasing," and
other similar terminology. These statements reflect
management's current expectations regarding future events and
operating performance and speak only as of the date of this release
materially. The acquired business may not perform as expected
or desired. There may be disruptions and/or expense relating to the
integration of the acquired business, which can impact the Company.
These forward-looking statements involve a number of risks and
uncertainties. For a description of factors that could cause
the Company's future results to differ from those expressed in any
such forward-looking statements, see Item 1A, entitled "Risk
Factors," in the Company's Annual Report on Form 10-K for the year
ended December 31, 2018. Except as required by law or
regulation, we undertake no obligation to publicly update any
forward-looking statements, whether as a result of new information,
future events, or otherwise.
About West
West Pharmaceutical Services, Inc. is a leading manufacturer of
packaging components and delivery systems for injectable drugs and
healthcare products. Working by the side of its customers from
concept to patient, West creates products that promote the
efficiency, reliability and safety of the world's pharmaceutical
drug supply. West is headquartered in Exton, Pennsylvania, and supports its
customers from locations in North and South America, Europe, Asia
and Australia. West's 2018 net
sales of $1.7 billion reflect the
daily use of approximately 112 million of its components and
devices, which are designed to improve the delivery of healthcare
to patients around the world. For more information, please visit
www.westpharma.com.
West and the diamond logo and By your side for a healthier
world™ are registered trademarks or trademarks of West
Pharmaceutical Services, Inc., in the
United States and other jurisdictions.
Media Contacts:
Jessie
Zhang
Global Communications, AP
West Pharmaceutical Services, Inc.
+86 21 31651821
jessie.zhang@westpharma.com
Emily Denney
Global Communications
West Pharmaceutical Services, Inc.
+ 1-610-594-3035
Emily.Denney@westpharma.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/west-expands-presence-in-korea-with-new-sales-office-300824096.html
SOURCE West Pharmaceutical Services, Inc.